Survodutide 10mg

Survodutide 10mg

$69.00

USD

Research Use Only (RUO) • Not for Human or Veterinary Use • Not for Consumption.

Survodutide peptide (BI 456906) is a research compound widely referenced in scientific and development literature as a GCGR/GLP-1R dual agonist (dual GLP-1 receptor and glucagon receptor pathway tool). This listing is supplied exclusively for in-vitro and non-clinical laboratory research focused on receptor signaling, pathway modeling, and controlled metabolic research readouts.

Peptides Skin supplies survodutide lyophilized powder as a research grade material to support reproducible laboratory workflows, with batch-based analytical verification and documentation support for qualified institutions.

What Is Survodutide (BI 456906) Research Peptide?

Survodutide (BI 456906) is commonly described as a dual GLP-1 + glucagon receptor agonist that engages both pathways in controlled models. In research context, this dual-target profile is used for mechanistic comparisons versus mono-agonist tools and for pathway-level evaluation in assay-dependent systems.

Dual GCGR/GLP-1R Agonism – Research Mechanism Context

  • GLP-1R pathway research: satiety signaling models, gastric emptying assays, and glucoregulatory pathway readouts (assay-dependent)
  • GCGR pathway research: energy metabolism signaling, substrate utilization markers, and bioenergetic panels (assay-dependent)
  • Dual-agonist study design: structured evaluation of combined pathway engagement under controlled experimental conditions

Research Context Keywords: Metabolic Models & Liver Research (MASH/NASH)

In public scientific and development context, BI 456906 (survodutide) is discussed in relation to metabolic programs and liver research areas such as MASH/NASH. This page does not make medical claims and is provided strictly for laboratory context only.

Technical Notes: 29-Amino-Acid Acylated Peptide (C18 Fatty Acid)

Survodutide is commonly referenced as a 29-amino-acid peptide with an acylation strategy that includes a C18 fatty acid / C18 diacid half-life extension motif described in research literature and technical references. Use-case and protocols remain assay-dependent.

Technical Specifications – Survodutide (BI 456906)

Research Name Survodutide (BI 456906)
Target Profile GCGR / GLP-1R dual agonist (research context)
CAS (commonly listed) 2805997-46-8
Peptide Length 29 amino acids
Molecular Weight (reference) ~4231.6 Da
Purity ≥99% (HPLC verified)
Form Lyophilized powder
Solubility Water, laboratory-grade saline, bacteriostatic water (protocol-dependent)
Testing HPLC / Mass Spectrometry (batch tested)
Documentation CoA available upon request
Grade Research Use Only (RUO)

Storage & Handling – Laboratory Workflow Guidelines (RUO)

  • Lyophilized powder: store cold, sealed, dry, and protected from light (commonly −20°C or below) per laboratory SOP
  • After preparation: maintain solutions under controlled refrigerated conditions per protocol; aliquot when appropriate
  • Best practice: avoid repeated freeze–thaw cycles to reduce variability
  • Handling: use sterile technique, appropriate PPE, and follow institutional lab safety procedures

Why Researchers Choose Peptides Skin – CoA, Traceability & Shipping

  • Analytical verification: HPLC/MS testing workflow to support reproducibility
  • CoA support: batch documentation available upon request for qualified institutions
  • Reliable supply: B2B-oriented fulfillment designed for laboratory procurement

FAQs – Survodutide (BI 456906) Research Compound

What is Survodutide (BI 456906) peptide?

Survodutide (BI 456906) is a GCGR/GLP-1R dual agonist research peptide supplied strictly for in-vitro and non-clinical laboratory research (RUO).

Is Survodutide approved for human use, injection, or supplementation?

No. This product is Research Use Only (RUO) and is not approved for human consumption, medical use, therapeutic use, diagnostic use, cosmetic use, or veterinary administration.

What receptors does Survodutide target in research context?

In research context, Survodutide is referenced for dual engagement of the GLP-1 receptor (GLP-1R) and glucagon receptor (GCGR) pathways in controlled models.

What does “BI 456906” mean?

BI 456906 is a development code commonly used in scientific and clinical-trial references for Survodutide in public literature.

Do you provide a Certificate of Analysis (CoA)?

Yes. A batch-specific CoA is available upon request for qualified laboratories and research institutions.

How should lyophilized Survodutide be stored?

Store cold, sealed, dry, and protected from light according to laboratory SOP. After preparation, avoid repeated freeze–thaw cycles to reduce variability.

RESEARCH USE ONLY (RUO):
For laboratory research and development purposes only. Not a drug, supplement, or food. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Any mention of biological pathways refers exclusively to controlled research models.